Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

Zenas BioPharma ZBIO announced that the phase III INDIGO study, which evaluated its lead pipeline candidate, obexelimab, for ...

So in general, really blinatumomab was very well tolerated. There were some more cytopenias in some of the patients with ...

PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral therapies for infection-associated ...

Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric disorders, today announced that the first participant has been dosed in the ...

Everywhere you look, there is a great deal of fear about the possibility of developing dementia as you get older. A new study ...

Researchers have identified specific psychological traits that indicate whether someone is likely to follow conspiracy ...

Adherence to a structured lifestyle intervention was nonsuperior to a self-guided intervention regarding impact on ...

Clinical trial evaluating changes in urine protein-to-creatinine ratio, a widely-accepted endpoint measuring risk reduction ...

Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...

Researchers will test whether the company's Genomic Prostate Score assay predicts disease progression and outcomes in a prospective cohort.